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Anaplasma phagocytophilum is an obligate intracel-
lular bacterium that invades neutrophils, creating
intravacuolar aggregates called morulae. It is
transmitted to humans and horses through Ixodes
tick bites and induces a febrile disease. This
research note describes the second equine case
conﬁrmed in France.
A 14-year-old French saddle horse from an area
where Ixodes ricinus ticks are endemic (Ecole
Polytechnique, Paris) was referred in May 2007
to the military veterinary clinic for fever and
depression. The horse was presented after having
received a single-dose penicillin treatment 24 h
before because of hyperthermia. The horse under-
went thorough clinical examination and blood
was collected for analysis, haematology and PCR.
Blood was stained with Hemacolor 61650 (Merck,
Darmstadt, Germany). DNA was extracted using
the QIAamp Tissue Kit and ampliﬁed and
sequenced by PCR using primers targeting the
citrate synthase (gltA) gene and 16S rRNA gene
[1].
Clinical signs included fever (39.5C), depres-
sion, anorexia, lethargy, mild icterus and reluc-
tance to move. No limb oedema was noted. The
blood count revealed a lymphopenia (745 ⁄mm3),
an anaemia and a thrombocytopenia
(67000 ⁄mm3). The horse received prior to other
examinations and analyses a single intramuscular
dose of 1.2 g of imidocarb dipropionate. An
attentive examination of the blood smears
showed later basophilic morulae inclusions in
the neutrophils, which was suggestive of Ana-
plasma phagocytophilum infection (Fig. 1). The PCR
on blood was positive for both genes and
sequencing analysis identiﬁed A. phagocytophilum
(similarity 100%). The horse recovered within
5 days without any treatment and fever disap-
peared within 48 h.
The ﬁrst case of European equine anaplasmosis
was conﬁrmed in 1998, by PCR and sequencing,
in a 12-year-old Arabian mare from an area where
ticks were endemic in Switzerland. The ﬁrst case
of Ehrlichia equi infection in an adult horse in
France was reported in 2002 [2]. The diagnosis
was conﬁrmed by PCR of a blood product and
serology (IFA). In France, many cases of fever of
unknown origin (FUO) in horses are treated
successfully with tetracycline by veterinary
practitioners. This led to the hypothesis that
A. phagocytophilum incidence might be underesti-
mated and responsible for a part of these cases as
suggested by previous epidemiological and
molecular studies [3]. The diagnosis of equine
anaplasmosis is a challenge if limb oedema and
ataxia are lacking, as other clinical signs are not
speciﬁc. Consequently, this diagnosis should be
investigated systematically when facing ‘fever of
unknown origin’, which is a frequent syndrome
in horses. Horses, indeed, are not well protected
from tick bites by ectoparasiticides because of
their weak remanency due to equine sudation.
This may explain the sporadic cases of ‘subclinical
babesiosis’ and even unrecognised cases of mild
anaplasmosis. In a case series of horses with FUO,
43% had a well-deﬁned infectious disease, 22%
had neoplasia, 6.5% had immune-mediated dis-
ease, 19% had miscellaneous causes, and in 9.5%
the cause was not determined [4].
Consequently, diagnosis by both PCR and
serology appears to be the most appropriate
method to conﬁrm a case. In an experimental
infection of six horses in Sweden, PCR signal was
consistently detected 2–3 days before appearance
of clinical signs and persisted 4–9 days after the
clinical signs cleared. Antibody response
appeared 12–16 days after inoculation and rap-
idly increased within 3–7 days of clinical illness
[5]. For an isolated fever in horses in endemic
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areas, blood smear examination easily detects
Anaplasma morulae that are present in the acute
phase.
The triad of blood smear ⁄PCR ⁄ serology allows
efﬁcient diagnosis of equine anaplasmosis. Fre-
quency of equine anaplasmosis is likely to be
underestimated in France. Even if recovery is
possible without it, treatment with intravenous
oxytetracycline for 3–7 days improves the recov-
ery and avoids more severe clinical signs.
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Fig. 1. Morula in a neutrophil on a blood smear stained
with the Haemacolor kit (arrow).
Boni et al. Isolated fever in horses 65
 2009 The Authors
Journal Compilation  2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15 (Suppl. 2), 64–65
